- Home
- ESTA vs PRCT Comparison
ESTA vs PRCT Comparison
Compare ESTA & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESTA | PRCT |
|---|---|---|
| Founded | 2004 | 2009 |
| Country | Costa Rica | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.0B |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ESTA | PRCT |
|---|---|---|
| Price | $76.49 | $32.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 9 |
| Target Price | ★ $78.14 | $51.13 |
| AVG Volume (30 Days) | 424.3K | ★ 1.4M |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $190,973,000.00 | ★ $299,907,000.00 |
| Revenue This Year | $29.18 | $48.30 |
| Revenue Next Year | $24.85 | $29.44 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 24.76 | ★ 50.07 |
| 52 Week Low | $26.56 | $27.80 |
| 52 Week High | $78.24 | $89.49 |
Technical Indicators
Market Signals| Indicator | ESTA | PRCT |
|---|---|---|
| Relative Strength Index (RSI) | 66.12 | 46.15 |
| Support Level | $73.56 | $31.70 |
| Resistance Level | $77.49 | $34.88 |
| Average True Range (ATR) | 3.16 | 1.63 |
| MACD | -0.14 | -0.27 |
| Stochastic Oscillator | 81.45 | 13.00 |
Price Performance
Historical ComparisonAbout ESTA Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.